These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31292804)

  • 1. Short- and Long-Term Outcomes of Patients Requiring Gastrectomy During Cytoreductive Surgery and Intraperitoneal Chemotherapy for Lower-Gastrointestinal Malignancies: A Propensity Score-Matched Analysis.
    Singh B; Fisher OM; Singh G; Lansom J; Bock M; Kozman M; Alzahrani N; Liauw W; Morris DL
    Ann Surg Oncol; 2019 Oct; 26(11):3627-3635. PubMed ID: 31292804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y; Aycart S; Mandeli JP; Heskel M; Sarpel U; Labow DM
    Surg Oncol; 2015 Sep; 24(3):264-9. PubMed ID: 26143715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Survival and Propensity Score Matched Outcomes of Bilateral
    Singh B; Singh G; Pourgholami M; Alzahrani N; Morris DL
    Anticancer Res; 2018 Oct; 38(10):5917-5921. PubMed ID: 30275219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term survival and perioperative propensity score matched outcomes of diaphragmatic resections compared to stripping in cytoreductive surgery + intra-peritoneal chemotherapy.
    Singh B; Singh G; Alzahrani N; Morris DL
    Am J Surg; 2020 Apr; 219(4):673-680. PubMed ID: 31255258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Munoz-Zuluaga C; Sardi A; King MC; Nieroda C; Sittig M; MacDonald R; Gushchin V
    Ann Surg Oncol; 2019 Feb; 26(2):473-481. PubMed ID: 30523470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM; Tobin L; Heavey SF; Kelly KJ; Roeland EJ; Lowy AM
    Ann Surg Oncol; 2015 May; 22(5):1716-21. PubMed ID: 25145504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.
    Polanco PM; Ding Y; Knox JM; Ramalingam L; Jones H; Hogg ME; Zureikat AH; Holtzman MP; Pingpank J; Ahrendt S; Zeh HJ; Bartlett DL; Choudry HA
    Ann Surg Oncol; 2016 Feb; 23(2):382-90. PubMed ID: 26429720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries.
    Mogal HD; Levine EA; Russell G; Shen P; Stewart JH; Votanopoulos KI
    Ann Surg Oncol; 2016 Feb; 23(2):534-8. PubMed ID: 26289808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term survival and perioperative propensity score matched outcomes in diaphragmatic interventions in cytoreductive surgery + intra-peritoneal chemotherapy.
    Singh B; Singh G; Alzahrani N; Arrowaili A; Morris DL
    Eur J Surg Oncol; 2019 Apr; 45(4):620-624. PubMed ID: 30611566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC.
    Munoz-Zuluaga C; King MC; Sardi A; Ledakis P; Sittig M; Nieroda C; MacDonald R; Gushchin V
    Ann Surg Oncol; 2019 Jul; 26(7):2268-2275. PubMed ID: 31041628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Jimenez W; Sardi A; Nieroda C; Sittig M; Milovanov V; Nunez M; Aydin N; Gushchin V
    Ann Surg Oncol; 2014 Dec; 21(13):4218-25. PubMed ID: 24986239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
    Enomoto LM; Choudry MH; Bartlett DL; Totin L; Mann GN; Skitzki JJ; Perry KC; Votanopoulos KI; Levine EA; Shen P
    Ann Surg Oncol; 2020 Jan; 27(1):107-114. PubMed ID: 31368017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic Model for Predicting Overall Survival in Patients with Peritoneal Surface Malignancy of an Appendiceal Origin Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Ihemelandu C; Fernandez S; Sugarbaker PH
    Ann Surg Oncol; 2017 Aug; 24(8):2266-2272. PubMed ID: 28342015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
    Votanopoulos KI; Bartlett D; Moran B; Haroon CM; Russell G; Pingpank JF; Ramalingam L; Kandiah C; Chouliaras K; Shen P; Levine EA
    Ann Surg Oncol; 2018 Mar; 25(3):674-678. PubMed ID: 29288288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis.
    Masckauchan D; Trabulsi N; Dubé P; Aubé-Lecompte ME; Cloutier AS; Mitchell A; Sideris L
    Surg Oncol; 2019 Mar; 28():69-75. PubMed ID: 30851915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis.
    El Halabi H; Gushchin V; Francis J; Athas N; Macdonald R; Nieroda C; Studeman K; Sardi A
    Ann Surg Oncol; 2012 Jan; 19(1):110-4. PubMed ID: 21701929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Reece L; Dragicevich H; Lewis C; Rothwell C; Fisher OM; Carey S; Alzahrani NA; Liauw W; Morris DL
    Ann Surg Oncol; 2019 Aug; 26(8):2622-2630. PubMed ID: 31123932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.
    Reghunathan M; Kelly KJ; Valasek MA; Lowy AM; Baumgartner JM
    Ann Surg Oncol; 2018 Mar; 25(3):702-708. PubMed ID: 29282599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases.
    Ihemelandu C; Mavros MN; Sugarbaker P
    Ann Surg Oncol; 2016 Dec; 23(13):4231-4237. PubMed ID: 27338748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy: Single-institutional experience with 1225 cases.
    Kyang LS; Alzahrani NA; Valle SJ; Rahman MK; Arrowaili A; Liauw W; Morris DL
    J Surg Oncol; 2019 Sep; 120(4):794-802. PubMed ID: 31309588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.